Marburg hemorrhagic fever laboratory findings: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Marburg hemorrhagic fever}} | {{Marburg hemorrhagic fever}} | ||
{{CMG}}{{AE}} | {{CMG}} {{AE}} {{ARK}} | ||
==Overview== | ==Overview== | ||
==Laboratory Studies== | ==Laboratory Studies== | ||
Revision as of 16:40, 20 October 2017
|
Marburg hemorrhagic fever Microchapters |
|
Differentiating Marburg hemorrhagic fever from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Marburg hemorrhagic fever laboratory findings On the Web |
|
American Roentgen Ray Society Images of Marburg hemorrhagic fever laboratory findings |
|
Risk calculators and risk factors for Marburg hemorrhagic fever laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
Overview
Laboratory Studies
It may be a challenge to clinically distinguish marburg virus disease (MVD) from other infectious diseases such as malaria, typhoid fever, shigellosis, meningitis and other viral haemorrhagic fevers. Marburg virus infection may be confirmed using the following diagnostic methods:
| Lab test for Marburg virus detection [1] |
|---|
| antibody-capture enzyme-linked immunosorbent assay (ELISA) |
| antigen-capture detection tests |
| Serum neutralization test |
| Reverse-transcriptase polymerase chain reaction (RT-PCR) assay |
| Antigen detection tests |
| Virus isolation by cell culture |
Tests on clinical samples present an extreme biohazard risk and are conducted only under maximum biological containment conditions. In deceased patients, immunohistochemistry, virus isolation, or PCR of blood or tissue specimens may be used to diagnose Marburg HF retrospectively.